Results From TAVR Clinical Trial Show Positive Outcomes for Patients in First 30 Days | MedStar Health
Results From TAVR Clinical Trial Show Positive Outcomes for Patients in First 30 Days
Friday, January 05, 2018

The researchers from MedStar Heart & Vascular Institute, led by Ron Waksman, MD, found, in their first-of-its-kind trial, that transcatheter aortic valve replacement in patients with low surgical risk showed no deaths or disabling strokes within 30 days of undergoing the procedure. This is a “strong signal” that it is safe for these patients as an alternative to the current standard of care. Read more.
Categories
Browse by Category
- View all categories
- Ambulatory
- Awards and Accreditation
- Cancer
- Cardiology
- Community Health
- Compliance
- COVID-19
- Diabetes
- Education
- Emergency
- Focus Blog
- Geriatrics
- Hand
- Healthcare Industry
- Healthcare Quality Improvement
- Innovation
- Medical Education
- MedStar Health in the Community
- MedStar Health System News
- MedStar Institute for Innovation
- MedStar Institute for Quality and Safety
- Neurosciences
- Nursing
- Orthopaedics and Sports Medicine
- Pediatrics
- Philanthropy
- Physical Therapy
- Primary Care
- Pulmonology
- Quality and Patient Safety
- Radiology
- Rehabilitation
- Research
- Transplant
- Urgent Care
- Urology
- Wellbeing
- Women’s services